Cyxtera Results Presentation Deck

Made public by

sourced by PitchSend

20 of 28

Creator

Cyxtera logo
Cyxtera

Category

Technology

Published

November 2022

Slides

Transcriptions

#1Cyxtera Q3 2022 Earnings Supplemental Data November 8, 2022 Cyxtera#2Disclaimer This presentation includes "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements contained in this presentation include statements concerning Cyxtera's estimated financial performance for 2022 and its plan to convert to a real estate investment trust ("REIT"). Because forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Cyxtera's control. Actual results and conditions (financial or otherwise) may differ materially from those indicated in the forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results and conditions to differ materially from those indicated in the forward-looking statements, including, but not limited to, the effects of the COVID-19 pandemic on Cyxtera's business or future results, including supply chain disruptions; Cyxtera's ability to maintain its credit ratings; Cyxtera's ability to access external sources of capital on favorable terms or at all, which could limit Cyxtera's ability to execute its business and growth strategies; increases in interest rates; fluctuations in energy prices; fluctuations in foreign currency exchange rates in the markets in which Cyxtera operates internationally; inflation; prolonged power outages, shortages or capacity constraints; physical and electronic security breaches and cyber-attacks, which could disrupt Cyxtera's operations; any failure of Cyxtera's physical infrastructure or negative impact on its ability to provide its services, or damage to customer infrastructure within its data centers; inadequate or inaccurate external and internal information, including budget and planning data, which could lead to inaccurate financial forecasts and inappropriate financial decisions; Cyxtera's fluctuating operating results; Cyxtera's government contracts, which are subject to early termination, audits, investigations, sanctions and penalties; Cyxtera's reliance on third parties to provide internet connectivity to its data centers; the incurrence of goodwill and other intangible asset impairment charges, or impairment charges to Cyxtera's property and equipment, which could result in a significant reduction to its earnings; the requirements of being a public company, including maintaining adequate internal controls over financial and management systems; Cyxtera's ability to manage its growth; volatility of the market price of Cyxtera's Class A common stock; future sales, or the perception of future sales, of Cyxtera Class A common stock by existing securityholders in the public market, which could cause the market price for Cyxtera's Class A common stock to decline; Cyxtera's ability to use its United States federal and state net operating losses to offset future United States federal and applicable state taxable income may be subject to certain limitations that could accelerate or permanently increase taxes owed; Cyxtera's ability to address the significant implementation and operational complexities required to complete a conversion to a REIT, including without limitation, completing internal reorganizations and modifying accounting and information technology systems, and receiving any necessary stakeholder and other approvals; Cyxtera's ability to apply highly technical and complex provisions of the US Internal Revenue Code, as amended, to its operations; and the timing to complete a conversion to a REIT, if at all. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the "Risk Factors" disclosed in Cyxtera's filings with the Securities and Exchange Commission ("SEC") from time to time. There may be additional risks that Cyxtera does not presently know or that it currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Cyxtera's expectations, plans or forecasts of future events and views as of the date of this presentation. Accordingly, you should not place undue reliance upon any such forward-looking statements in this presentation. Neither Cyxtera nor any of its affiliates assume any obligation to update this presentation, except as required by law. Statement Regarding Non-GAAP Financial Measures This presentation contains Transaction Adjusted EBITDA, which is a supplemental measure that is not required by, or presented in accordance with, accounting principles generally accepted in the United States ("GAAP"). Transaction Adjusted EBITDA represents the measure of EBITDA disclosed to Starboard Value Acquisition Corp ("SVAC") in connection with its consideration of the business combination transaction between SVAC and Cyxtera. Cyxtera defines Transaction Adjusted EBITDA as net income (loss) before the following items: depreciation and amortization, interest and other expenses, net, income tax expense (benefit), equity- based compensation, straight-line rent adjustment, amortization of favorable / unfavorable leasehold interest & asset retirement obligation accretion, stand-up separation & other, restructuring costs & other, and change in fair value of warrant liabilities. As a Non-GAAP financial measure, Transaction Adjusted EBITDA excludes items that are significant in understanding and assessing Cyxtera's financial results or position. Therefore, this measure should not be considered in isolation or as an alternative to net income, cash flows from operations or other measures of profitability, liquidity or performance under GAAP. You should be aware that Cyxtera's presentation of this measure may not be comparable to similarly-titled measures used by other companies. Refer to the Appendix to this presentation, which includes a reconciliation of the non-GAAP financial measures included in this presentation to the most directly comparable GAAP financial measures. This presentation also includes certain projections of non-GAAP financial measures concerning Cyxtera. Due to the high variability and difficulty in making accurate forecasts and projections of some of the information excluded from these projected measures, together with some of the excluded information not being ascertainable or accessible, Cyxtera is unable to quantify certain amounts that would be required to be included in the most directly comparable GAAP financial measures without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included and no reconciliation of the forward-looking non-GAAP financial measures is included. This presentation includes constant currency revenue, MRR, and Transaction Adjusted EBITDA, which are non-GAAP financial measures and are not meant to be considered in isolation or as an alternative to GAAP revenue and GAAP net income (loss). Cyxtera has presented these non-GAAP financial measure to provide investors with an additional tool to evaluate its results without the impact of fluctuations in foreign currency exchange rates, thereby facilitating period-to-period comparisons of Cyxtera's business performance. To present this information, Cyxtera's current and comparative prior period revenues and certain operating expenses from entities with functional currencies other than the U.S. dollar are converted into U.S. dollars at a consistent exchange rate for purposes of each result being compared. Cyxtera 2#3Presenters Cyxtera Nelson Fonseca - Chief Executive Officer Carlos Sagasta - Chief Financial Officer 3#4Q3 2022 Financial and Business Highlights ● ● ● ●. ● Total revenue increased by $9.5 million, or 5.4% year over year, to $186.6 million in the third quarter On a constant currency basis, total revenue increased by $14.1 million, or 8.0% year over year Core revenue increased by $11.8 million, or 7.3% year over year, to $172.8 million in the third quarter Interconnection revenue increased to 11.6% of Total Revenue Q3 stabilized occupancy increased 480 bps year over year to 73.7% Cyxtera ● ● ● ● Transaction Adjusted EBITDA increased by $0.4 million, or 0.8% year over year, to $58.5 million in the third quarter On a constant currency basis, Transaction Adjusted EBITDA increased by $2.8M, or 4.9% year over year Strong Core Churn performance in Q3 of 0.8% with YTD Core Churn also at 0.8%, 10bps lower year over year YTD Continued bookings momentum with 11th consecutive quarter of positive net bookings ● ● ● ● Closed an AR securitization facility of $37.5 million with PNC Bank, N.A., providing increased availability and reduced interest expense as we continue to proactively manage liquidity Solid pricing dynamics and increasing revenue per cabinet Consistent with long-term strategic plan, announced the intention to convert to a REIT Affirming full year guidance despite continued FX volatility, rising utility costs and higher interest rates#5Core Revenue & Churn Core Revenue ($ in Millions) Cyxtera $161.0 Q3'21 $162.5 Q4'21 $165.9 Q1'22 $168.8 7.3% year over year growth in Core Revenue Q2'22 Q3'22 Core Revenue of $172.8M (vs. $161.0M prior year) Note: Figures exclude Revenue and Churn associated with Lumen as a customer $172.8 Q3'22 Core Churn (Core Churn % of Average Core MRR) 0.7% Q3'21 0.6% Q4'21 1.0% Q1'22 0.7% Q2'22 0.8% Q3'22 Normalized for SIN1 Core Churn would be 0.7% in Q3 Minimal exposure to SMB segment provides stable performance Good visibility on near term churn with no material differences among markets 01#6Q3 2022 Occupancy 2022 YTD Stabilized Market Occupancy Bridge 71.4% Q4'21 Cyxtera 2.8% Stabilized (1) Markets -0.5% Lumen 73.7% Q3'22 (2) Stabilized Market Occupancy Trend 68.9% Q3'21 (1) Stabilized Markets are markets that have been in operation for more than 3 years or have an occupancy rate greater than 50%. Stabilized Markets excludes partner sites. (2) Q3'22 occupancy would have been 75.5% adjusted for customer deals that closed in the last days of the quarter. 71.4% Q4'21 +4.8% YoY 70.5% Q1'22 74.2% Q2'22 73.7% Q3'22(2)#72022 Priorities Organic Growth ● Strategic Growth Focus on accretive geographic expansion opportunities with disciplined approach to capital allocation and returns ● Maintain occupancy growth in line with 2020/21 performance Increase core revenue growth and continue churn stabilization and reduction Accelerate channel partnership sales and new logo momentum ● Explore avenues for greater property control and ownership Expand liquidity and capital funding diversification Cyxtera Innovation ● ESG Focus ● Continued interconnection growth Accelerate adoption of Digital Exchange and Bare Metal platforms Deliver enhanced flexibility to customers by increasing automation and ease of Data Center consumption ● Maintain focus on being responsible stewards of the environment with increased disclosures and strong governance Committed to achieving 100% non-carbon emitting energy consumption by 2030 Continued focus on Employee development and increasing diversity and inclusion in leadership positions 7#8Financial Overview#9Q3 2022 Financial Highlights Revenue ($ in Millions) $177.1 $169.3 Q3'21 Cyxtera $178.4 $170.3 Q4'21 $182.4 $173.7 Q1'22 Consecutive quarters of total revenue growth Non-Recurring $184.1 $174.2 Q2'22 8 Recurring $186.6 $178.1 Q3'22 Transaction Adjusted EBITDA ($ in Millions) $58.1 Q3'21 $48.0 Q4'21 $58.6 Q1'22 YOY change in Transaction Adjusted EBITDA $60.0 Q2'22 0.8% $58.5 Q3'22#10Core Revenue & Churn Core Revenue ($ in Millions) Cyxtera $161.0 Q3'21 $162.5 Q4'21 $165.9 Q1'22 $168.8 7.3% year over year growth in Core Revenue Q2'22 Q3'22 Core Revenue of $172.8M (vs. $161.0M prior year) Note: Figures exclude Revenue and Churn associated with Lumen as a customer $172.8 Q3'22 Core Churn (Core Churn % of Average Core MRR) 0.7% Q3'21 0.6% Q4'21 1.0% Q1'22 0.7% Q2'22 0.8% Q3'22 Normalized for SIN1 Core Churn would be 0.7% in Q3 Minimal exposure to SMB segment provides stable performance Good visibility on near term churn with no material differences among markets 10#11Q3 2022 Results Core revenue increased by $11.8 million, or 7.3%, year over year to $172.8 million Transaction Adjusted EBITDA increased by $0.4 million or 0.8% year over year, to $58.5 million, principally due to higher revenue partially offset by higher cost of revenue and SG&A costs Cyxtera ($ in Millions) Recurring Revenue Non-Recurring Revenue Total Revenue Cost of Revenue As a % of Revenue Gross Profit % Margin Total SG&A As a % of Revenue Other (1) EBITDA % Margin Transaction Adjustments Transaction Adjusted EBITDA (2) % Margin Rent (net of adjustments) Transaction Adjusted EBITDAR(3) % Margin Capital Expenditures As a % of Revenue (1) Q3 22 includes $1.3M in restructuring, impairment, site closures and related cost. Q3 21 includes $4.1M in restructuring, impairment, site closures and related cost (2) Earnings Before Interest, Taxes, Depreciation, Amortization (3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent Q3 '22 $178.1 8.5 $186.6 $100.3 53.8% $86.2 46.2% $37.9 20.3% $1.3 $47.1 25.3% $11.4 $58.5 31.4% $15.0 $73.5 39.4% $38.5 20.6% Q3 '21 $169.3 7.8 $177.1 $93.5 52.8% $83.5 47.2% $29.2 16.5% $9.3 $45.1 25.4% $13.0 $58.1 32.8% $15.7 $73.8 41.7% $21.4 12.1% YOY Change 5.2% 9.3% 5.4% 7.3% 96 bps 3.2% (96 bps) 29.4% 377 bps ΝΑ 4.6% (19 bps) 0.8% (143 bps) (0.3%) (226 bps) 79.4% 851 bps 11#12Q3 YTD 2022 Results Core revenue increased by $30.8 million, or 6.5%, year over year to $507.5 million Transaction Adjusted EBITDA increased by $0.7 million or 0.3% year over year, principally due to higher revenue partially offset by higher higher cost of revenue and SG&A costs Cyxtera ($ in Millions) Recurring Revenue Non-Recurring Revenue Total Revenue Cost of Revenue As a % of Revenue Gross Profit % Margin Total SG&A As a % of Revenue Other (1) EBITDA % Margin Transaction Adjustments Transaction Adjusted EBITDA (2) % Margin Rent (net of adjustments) Transaction Adjusted EBITDAR(3) % Margin Capital Expenditures As a % of Revenue Q3 YTD 2022 $526.0 27.0 $553.0 $296.7 53.7% $256.3 46.3% $103.8 18.8% ($7.9) $160.4 29.0% $16.7 $177.1 32.0% $45.6 $222.6 40.3% $102.8 18.6% Q3 YTD 2021 $501.2 24.1 $525.3 $287.4 54.7% $238.0 45.3% $79.7 15.2% (1) Q3 22 YTD includes ($11.8M) benefit related to change in fair value of derivative liabilities, offset by $3.9M in restructuring, impairment, site closures and related cost. Q3 21 YTD includes $71.1M in restructuring, impairment, site closures and related cost (2) Earnings Before Interest, Taxes, Depreciation, Amortization (3) Earnings Before Interest, Taxes, Depreciation, Amortization & Rent $76.3 $82.0 15.6% $94.5 $176.4 33.6% $46.0 $222.5 42.4% $48.5 9.2% YOY Change 4.9% 12.3% 5.3% 3.3% (105 bps) 7.7% 105 bps 30.2% 360 bps ΝΑ 95.7% 1,340 bps 0.3% (157 bps) 0.1% (210 bps) 112.0% 936bps 12#13Constant-Currency Analysis 5.4% 8.0% Q3 YOY REVENUE GROWTH 0.8% 4.9% Q3 YOY AEBITDA GROWTH 5.3% Cyxtera (1) YoY represents change in F/X rates Sep 2022 vs Sep 2021 7.0% Q3 YTD REVENUE GROWTH ■As Reported Constant Currency 0.4% 2.8% Q3 YTD AEBITDA GROWTH Revenue Exposure by Currency (¹) 79% 9% 5% 4% 1% 1% 1% USD GBP SGD CAD EURO JPY OTHER 19% YoY 5% YoY 7% YoY 16% YoY 23% YoY 13#14Revenue Bridge: Q3 2021 to Q3 2022 ($ in Millions) Cyxtera $177.1 Q3'21 +$15.5 Core Net Revenue -$1.6 Lumen Net Revenue -$4.6 FIX $186.6 Q3'22 14#15Exit MRR Bridge: YE 2021 to YTD 2022 ($ in Millions) $53.5 Q4'21 Cyxtera Core MRR Increase +$4.1MM +$8.3 Core Installations -$4.2 Core Disconnects $0.2 Lumen Installs -$0.7 Lumen Net Disconnects -$1.4 FX $55.8 Q3'22 Core MRR excl. FX increased by $4.1M or 8.4% to $52.8MM primarily due to net installations 15#16Cost of Revenue Bridge: Q3 2021 to Q3 2022 ($ in Millions) Cyxtera $93.5 Q3'21 $7.6 Utilities -$0.9 Rent -$2.1 Installation Costs $2.3 PY Vendor Settlement and Other $100.3 Q3'22 16#17Summary of Total Power Costs ($ in Millions) Cyxtera Total International U.S. Deregulated U.S. Regulated 100% (1) Hedging not available in U.S. Regulated markets. 22% 43% 35% 3Q21A Long Term Fixed Contract Position Relative to Consumption in U.S. Deregulated & International Markets (¹) Long Term Fixed Contract Consumption 38% 100% 22% 45% 33% 3Q22A 50% YOY Change 19% 18% 24% 13% 17#18Transaction Adjusted EBITDA Bridge: Q3 2021 to Q3 2022 ($ in Millions) Cyxtera (1) (2) $58.1 Q3'21 + $9.5 Change in Revenue -$6.8 Change in Cost of Revenue (2) -$8.6 Change in SG&A +$6.4 Change in Adjustments (1)(2) $58.5 Q3'22 Includes pro forma EBITDA adjustments related to one-time stand-up costs, recurring expenses, restructuring & cost-savings initiatives, as well as product development & start-up costs Excludes $1.3M in restructuring, impairment, site closures and related cost in Q3 22 and $5.2M of transaction related expenses, $2.7M of change in fair value of warrant liabilities and $1.4M in restructuring, impairment, site closures and related cost in Q3 21 18#19Capital Expenditures Q3 2022 CapEx (1) ($ in Millions) 18.3% $34.2 Expansion Q3 2021 CapEx (1) 8.5% $15.0 Expansion Cyxtera 1.8% $3.3 Maintenance 3.2% $5.7 ■ $-Amount Maintenance % of Revenue 0.5% $0.9 Corporate ■$-Amount % of Revenue 0.4% $0.7 Corporate 20.6% $38.5 Total 12.1% $21.4 Total YTD 2022 CapEx (1) ($ in Millions) 15.6% $86.4 Expansion YTD 2021 CapEx (1) 6.7% $35.2 Expansion (1) Cash CapEx was $38.1MM and $15.9MM in Q3'22 and Q3'21, respectively and was $100.4MM and $44.1MM in YTD 2022 and YTD 2021 respectively. 2.6% $14.6 Maintenance 2.1% $11.1 Maintenance $-Amount % of Revenue 0.3% $1.8 Corporate $-Amount % of Revenue 0.4% $2.2 Corporate 18.6% $102.8 Total 9.2% $48.5 Total 19#20Leverage Trend Cyxtera 6.2 Q3'21 3.7 6.4 Q4'21 3.8 6.1 Lease Adj. Leverage (¹) 6.3 3.6 TË Q1'22 Q2'22 3.8 Financial Net Leverage (2) 6.2 Q3'22 3.6 (1)) Lease Adjusted Leverage is calculated by dividing financial net debt and secured capital leases + 5x real estate lease payments (5x methodology based on Moody's Communications Infrastructure sector lease capitalization multiple) by LTM Q3 2022A Transaction Adj. EBITDAR; (2) Financial Net Leverage is calculated by dividing Financial Net Debt (Net Debt, adjusted to exclude all Capital Lease obligations) by LTM Q3 2022A Transaction Adj. EBITDA. 20#212022 Financial Guidance Cyxtera ($ in Millions) Revenue Transaction Adjusted EBITDA Maintenance Capital Expenditures % of Revenue Expansion Capital Expenditures 2022E $730 - $760 $232 - $242 $26 $28 3.6% - 3.7% $102 - $127 2021A $703.7 $224.4 $21.3 3.0% $67.3 % Change 4% - 8% 3% - 8% 22% -32% 60-70 bps 52% -89% 21#22Appendix#23Reconciliation of GAAP to Non-GAAP Results CYXTERA TECHNOLOGIES, INC. RECONCILIATION OF GAAP TO NON-GAAP RESULTS For Three Months Ended September 30, 2022, and 2021 (unaudited, in millions) Cyxtera Net Loss to EBITDA Reconciliation: Net loss Depreciation and amortization Interest and other expenses, net Income tax benefit EBITDA Transaction Adjustments Equity-based compensation Straight-line rent adjustment Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion Stand-up separation & other Restructuring costs & other REIT conversion costs Transaction-related costs Change in fair value of warrant liabilities Total Adjustments Transaction Adjusted EBITDA Note: Numbers may not foot or cross-foot due to rounding $ $ Three Months Ended September 30, 2021 2022 (55.9) 60.0 43.5 (0.5) $47.1 6.2 0.4 0.9 1.5 1.3 1.0 11.4 58.5 (46.7) 59.4 43.5 (11.1) 45.1 1.8 0.6 0.9 0.4 1.4 5.2 2.7 13.0 58.1 23#24Reconciliation of GAAP to Non-GAAP Results CYXTERA TECHNOLOGIES, INC. RECONCILIATION OF GAAP TO NON-GAAP RESULTS For Nine Months Ended September 30, 2022, and 2021 (unaudited, in millions) Cyxtera Net Loss to EBITDA Reconciliation: Net loss Depreciation and amortization Interest and other expenses, net Income tax expense (benefit) EBITDA Transaction Adjustments Equity-based compensation Straight-line rent adjustment Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion Stand-up separation & other Restructuring costs & other REIT conversion costs Transaction-related costs Change in fair value of warrant liabilities Total Adjustments Transaction Adjusted EBITDA Note: Numbers may not foot or cross-foot due to rounding SA $ $ Nine Months Ended September 30, 2022 2021 (144.9) 183.1 120.6 1.6 160.4 16.0 1.5 2.7 2.7 3.9 1.7 (11.8) 16.7 177.1 (192.3) 180.6 130.5 (36.9) 81.9 5.4 2.5 2.6 3.8 72.3 | 5.2 2.7 94.5 176.4 24#25Capitalization ($ in Millions) Cash and Cash Equivalents Revolver (Maturing 11/2023) 1st Lien Debt (Maturing 5/2024) Capital Leases Total Debt Net Debt (¹) Less: Optional renewal portion of Capital Leases Contractual Net Debt (Excl. Optional Capital Leases) Less: Contractually obligated Capital Leases Less: Equipment Leases Financial Net Debt (Excl. All Capital Leases) Key Credit Metrics TTM Transaction Adj. EBITDA/Net Leverage (4) TTM Transaction Adj. EBITDA/ Contractual Net Leverage (5) TTM Transaction Adj. EBITDAR/Lease Adjusted Leverage (6) TTM Transaction Adj. EBITDA/Financial Net Leverage (7) Total Liquidity Cyxtera Rate L + 300 bps L +300 bps (2) Metric 225 225 286 225 9/30/2022 $86 42 864(3) 1,118 $2,025 1,938 (204) 1,735 (870) (45) 820 8.6x 7.7 6.2 3.6 $159 Rate L + 300 bps L + 300 bps Metric 224 224 286 224 (2) 6/30/2022 $40 20 868 (3) 1,121 $2,009 1,969 (208) 1,761 (878) (35) 848 8.8x 7.8 6.3 3.8 $135 (1) Net Debt is equal to total debt minus cash and cash equivalents; (2) Incremental $100m First Lien Term Loan Interest rate of L + 400 bps; (3) Debt balances are based on GAAP reporting and are shown gross of unamortized issuance costs; (4) Net leverage is calculated by dividing net debt by LTM Q3 2022A Transaction Adj.EBITDA; (5) Contractual Net Leverage is calculated by dividing Contractual Net Debt (which includes the GAAP calculation of Capital Lease obligations, adjusted to exclude obligations attributable to the term of any future lease extension option exercisable at the Company's discretion) by LTM Q3 2022A Transaction Adj.EBITDA; (6) Lease Adjusted Leverage is calculated by dividing financial net debt and secured capital leases + 5x real estate lease payments (5x methodology based on Moody's Communications Infrastructure sector lease capitalization multiple) by LTM Q3 2022A Transaction Adj. EBITDAR; (7) Financial Net Leverage is calculated by dividing Financial Net Debt (Net Debt, adjusted to exclude all Capital Lease obligations) by LTM Q3 2022A Transaction Adj.EBITDA. 25#26Cyxtera ©2022 Cyxtera Technologies, Inc. All Rights Reserved. The Cyxtera logo and certain product names are the property of Cyxtera. All other marks are the property of their respective owners.

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

1st Quarter 2021 Earnings Presentation image

1st Quarter 2021 Earnings Presentation

Technology

Rackspace Technology Q4 2022 Earnings Presentation image

Rackspace Technology Q4 2022 Earnings Presentation

Technology

CBAK Energy Technology Investor Presentation image

CBAK Energy Technology Investor Presentation

Technology

Jianpu Technology Inc 23Q1 Presentation image

Jianpu Technology Inc 23Q1 Presentation

Technology

High Performance Computing Capabilities image

High Performance Computing Capabilities

Technology

SOLOMON Deep Learning Case Studies image

SOLOMON Deep Learning Case Studies

Technology

1Q20 Earnings image

1Q20 Earnings

Technology

Nutanix Corporate Overview image

Nutanix Corporate Overview

Technology